In fact, neither an acutely introduced long-term insulin treatment did not improve survival in type 2 diabetic patients following myocardial infarction when compared with a conventional management at similar levels of glucose control nor an insulin-based treatment lowers the number of nonfatal myocardial reinfarctions and strokes [40]. This evidence concerns the gene INS and myocardial infarction.